Skip to content

Commit

Permalink
Merge pull request #12 from conorheffron/readme-doc-up
Browse files Browse the repository at this point in the history
Update ReadMe.md
  • Loading branch information
conorheffron committed Mar 29, 2024
2 parents 80f534e + e96622d commit f4f3355
Showing 1 changed file with 5 additions and 10 deletions.
15 changes: 5 additions & 10 deletions ReadMe.md
Original file line number Diff line number Diff line change
@@ -1,15 +1,10 @@
# Summary
### Summary

In this report, I will analyse a publicly available dataset based on clinical breast cancer data. Breast cancer is the most diagnosed cancer in women. There are several subtypes of diseases characterized by different genetic drivers for cancer risk
and tumour growth. The human epidermal growth factor receptor 2 amplified (HER2: ERBB2 / ERBB2IP) breast cancer is one of the most aggressive subtypes. In addition, I will investigate HER3 (ERBB3), HER4 (ERBB4), PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 gene mutations. Although there are targeted therapies that have been developed to treat these cancer cases, the response rate ranges from 40% - 50%. I will download, decompress, clean and process the TCGA
RNASeq data for breast cancer from cbioportal and identify the differentially expressed genes between ERBB2 / ERBB2IP, ERBB3, ERBB4, PIK3C2B, MDM4, L
RRN2, NFASC, KLHDC8A, and CDK18 cancer tumours.
The dataset can be downloaded from this link:
https://www.cbioportal.org/study/summary?id=brca_tcga_pan_can_atlas_2018.
- In this report, I will analyse a publicly available dataset based on clinical breast cancer data. Breast cancer is the most diagnosed cancer in women. There are several subtypes of diseases characterized by different genetic drivers for cancer risk and tumour growth. The human epidermal growth factor receptor 2 amplified (HER2: ERBB2 / ERBB2IP) breast cancer is one of the most aggressive subtypes. In addition, I will investigate HER3 (ERBB3), HER4 (ERBB4), PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 gene mutations. Although there are targeted therapies that have been developed to treat these cancer cases, the response rate ranges from 40% - 50%. I will download, decompress, clean and process the TCGA RNASeq data for breast cancer from cbioportal and identify the differentially expressed genes between ERBB2 / ERBB2IP, ERBB3, ERBB4, PIK3C2B, MDM4, LRRN2, NFASC, KLHDC8A, and CDK18 cancer tumours.
- The dataset can be downloaded from this [link](https://www.cbioportal.org/study/summary?id=brca_tcga_pan_can_atlas_2018)

### **Run All Code Chunks in _`assignment-2.qmd`_ from RStudio project**

**Run All Code Chunks in _`assignment-2.qmd`_ from RStudio project**

**Render PDF or HTML**
#### **Render PDF or HTML**

### See full report in html or pdf format at: [Full Report](https://conorheffron.github.io/gene-expr/assignment-2.html)

0 comments on commit f4f3355

Please sign in to comment.